ViroPharma Receives Orphan Drug Designation For Maribavir For Cytomegalovirus Viremia And Disease Indication
Thu, 08 Feb 2007 08:00 AM EST
... ViroPharma Incorporated (Nasdaq: VPHM) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for maribavir for prevention of cytomegalovirus (CMV) viremia and disease in the populations at-risk. [click link for full article] ...
Related Topics
- Cytomegalovirus
- Cytomegalovirus Infections
- Drug Safety
- Prescription Drugs
- Cytomegalovirus / Cmv
- Cytomegalovirus Infection
- Diseases & Conditions
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Crohn's Disease
- Graves' Disease

Not Signed In -


